Kivo Health Raises $10M Series A to Scale AI-Powered Virtual Pulmonary Rehab

Kivo Health Closes $10M Series A

Kivo Health, a San Francisco-based digital health company, has raised a $10 million Series A round. The round was led by Allumia Ventures, with participation from MassMutual Ventures, Y Combinator, Liquid 2 Ventures, and the UCSF Rosenman Institute.

What Kivo Health Does

Kivo Health provides AI-powered virtual pulmonary rehabilitation for seniors with chronic lung disease, starting with COPD. Patients complete an 8-week, insurance-covered program from home through live video sessions with respiratory therapists. The company ships a kit that includes a cell-connected iPad and a Bluetooth pulse oximeter, enabling remote monitoring and guided therapy without requiring patients to travel to a clinic.

Payer and Health System Traction

The company works with health systems and payers including Stanford Health Care, UCLA, Optum, and Priority Health. According to Kivo Health, its program saves payers thousands of dollars per patient by keeping members out of the hospital.

Investor Profile

The round brings together a mix of venture and strategic backers:

• Allumia Ventures (lead)
• MassMutual Ventures
• Y Combinator
• Liquid 2 Ventures
• UCSF Rosenman Institute

Kivo Health is a Y Combinator Winter 2023 alum, and Y Combinator's continued participation signals ongoing conviction in the company's model.

Why It Matters for Acquisition Watchers

Kivo Health sits at the intersection of two durable healthcare trends: the shift of rehabilitation and chronic care into the home, and payer pressure to reduce avoidable hospital admissions. Its insurance-covered model and existing relationships with major health systems and payers give it a distribution footprint that strategic acquirers in digital health, payer services, or respiratory care may find attractive.

The Series A capital is positioned to support the company as it scales its virtual pulmonary rehab offering across its health system and payer partners.

Round Summary

• Company: Kivo Health
• Round: Series A
• Amount: $10,000,000 USD
• Lead investor: Allumia Ventures
• Additional investors: MassMutual Ventures, Y Combinator, Liquid 2 Ventures, UCSF Rosenman Institute
• Sector: Digital health / virtual pulmonary rehabilitation
• Headquarters: San Francisco